Investment surges, hurdles and emerging innovations in neuroscience
Pharmaceutical Technology
NOVEMBER 10, 2024
Experts in the neuropsychiatry drug development space say targeting the right patient population will be key for success in the field.
Sun.Nov 10, 2024
130 
J&J bids to add smouldering myeloma to Darzalex label
pharmaphorum
NOVEMBER 10, 2024
Johnson & Johnson looks on course to make Darzalex the first approved drug therapy for smouldering multiple myeloma, after a phase 3 win
Join 21,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Midline vs Peripherally Inserted Central Catheter for Outpatient Parenteral Antimicrobial Therapy
JAMA Internal Medicine
NOVEMBER 10, 2024
This cohort study compares outcomes from midline catheters vs peripherally inserted central catheters for outpatient parenteral antimicrobial therapy.
Aignostics leads latest crop of digital health financings
pharmaphorum
NOVEMBER 10, 2024
Recent funding rounds in the digital health arena feature digital pathology startup Aignostics, remote care specialists TCC, Yazen Health, and Nema Health, wearables developer Alimetry, and clinical trial automation startup Research Grid.Digital pathology specialist Aignostics, which develops artificial intelligence algorithms to glean information from medical images and combine it with epidemiological, clinical, and genomic data, has completed a $34 million Series B financing.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Overtreatment of Prostate Cancer Among Men With Limited Longevity in the Active Surveillance Era
JAMA Internal Medicine
NOVEMBER 10, 2024
This cohort study examines if rates of overtreatment of men with prostate cancer with limited life expectancy have persisted in the active surveillance era and whether overtreatment varies by tumor risk or treatment type.
Regulator and Funder? FDA’s Orphan Products Grants Program awards significant funding to help move promising treatments through clinical development
FDA Law Blog
NOVEMBER 10, 2024
By Sarah Wicks & James E. Valentine — The U.S. Food and Drug Administration (FDA) plays a pivotal role in fostering the development of treatments for rare diseases through its Orphan Products Grants Program. Each year, FDA selects a limited number of clinical trials to fund to help sponsors pursue development of medical products for rare diseases and advance their field.
Sign up to get articles personalized to your interests!
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
More Trending
Consumer Wearables—Advancing Atrial Fibrillation Care or Too Much Information?
JAMA Internal Medicine
NOVEMBER 10, 2024
This Viewpoint describes the diffusion of direct-to-consumer wearable devices capable of early atrial fibrillation detection and the unclear implications for initiation of anticoagulation therapy based on such findings.
DBT soon to begin research on consequences of viral infection on cardiovascular health & prevention strategies
AuroBlog - Aurous Healthcare Clinical Trials blog
NOVEMBER 10, 2024
The Department of Biotechnology (DBT) has invited researchers, scientists and clinicians to collaborate in multicentric projects to study consequences of viral infection including post Covid-19 impact on cardiovascular health, and prevention strategies, in order to gain insights into the therapeutic segment.
Scientists Reveal How Much Sleep You Need For ‘Successful Aging’
AuroBlog - Aurous Healthcare Clinical Trials blog
NOVEMBER 10, 2024
(Yulia Petrova/Getty Images) We all want to ‘age successfully’ with as few health issues as possible. A new study suggests getting more than seven hours of sleep a night could go a long way to achieving that goal.
Let's personalize your content